The current number of shares outstanding for BioGene is 23 million and its current PE ratio is 49. Assuming a yearly gro
Posted: Thu May 26, 2022 7:07 am
The current number of shares outstanding for BioGene is
23 million and its current PE ratio is 49. Assuming a yearly growth
in earnings of 50 per- cent for the next four years and a decline
in the PE ratio to 25, this implies a valuation of $962 million in
2022. Assume InterWebs earnings (after-tax profits) in 2022 are
$6.3 million as stated in their business plan. Assigning a PE ratio
of 50 of InterWeb in 2022, what will be their
valuation?
23 million and its current PE ratio is 49. Assuming a yearly growth
in earnings of 50 per- cent for the next four years and a decline
in the PE ratio to 25, this implies a valuation of $962 million in
2022. Assume InterWebs earnings (after-tax profits) in 2022 are
$6.3 million as stated in their business plan. Assigning a PE ratio
of 50 of InterWeb in 2022, what will be their
valuation?